Presentation is loading. Please wait.

Presentation is loading. Please wait.

by Elham Kamangar, and Weiqiang Zhao

Similar presentations


Presentation on theme: "by Elham Kamangar, and Weiqiang Zhao"— Presentation transcript:

1 by Elham Kamangar, and Weiqiang Zhao
Hemophagocytosis in a patient with persistent chronic lymphocytic leukemia by Elham Kamangar, and Weiqiang Zhao Blood Volume 122(13): September 26, 2013 ©2013 by American Society of Hematology

2 A 73-year-old male with a medical history of chronic lymphocytic leukemia (CLL) with urinary infection presented with fever (101.6°F) and pancytopenia (white blood cells 1.0 K/μL, platelets 54 K/μL, and hemoglobin 7.8 g/dL). A 73-year-old male with a medical history of chronic lymphocytic leukemia (CLL) with urinary infection presented with fever (101.6°F) and pancytopenia (white blood cells 1.0 K/μL, platelets 54 K/μL, and hemoglobin 7.8 g/dL). Viral and fungal studies were negative. A bone marrow study was performed and showed persistent CLL and the presence of numerous phagocytosed lymphocytes and red blood cells by histiocytes. The figure shows characteristic engulfed red blood cells and lymphocytes by histiocytes (panel A: iron stain; panels B-C: Wright-Giemsa stain). Further laboratory tests demonstrated elevated ferritin (45 077 mg/dL), hypertriglyceridemia (4 mmol/L), hypophosphatemia (0.5 g/L), and hepatocellular pattern of transaminitis. The clinicopathological findings of this patient met the diagnostic criteria of hemophagocytic syndrome or hemophagocytic lymphohistiocytosis (HLH), a systemic, progressive, and often fatal disorder. Clinical improvement was observed after the patient was treated with etoposide and dexamethasone. Two major forms of HLH have been described, familial (FHLH) and secondary or acquired (AHLH). FHLH is an autosomal recessive disorder prevalently seen in parental consanguinity. AHLH occurs secondary to systemic infection, immunodeficiency, and underlying malignancy, such as CLL in this patient. Treatment with immunosuppressive and/or chemotherapeutic agents might alleviate the disorder, although poor clinical outcomes of HLH were reported when associated with hematologic malignancies. Elham Kamangar, and Weiqiang Zhao Blood 2013;122:2149 ©2013 by American Society of Hematology


Download ppt "by Elham Kamangar, and Weiqiang Zhao"

Similar presentations


Ads by Google